CIC
Cornercap Investment Counsel Portfolio holdings
AUM
$192M
This Quarter Return
+0.77%
1 Year Return
+17.05%
3 Year Return
+45.89%
5 Year Return
+105.96%
10 Year Return
+138.93%
AUM
$568M
AUM Growth
+$568M
(-1.6%)
Cap. Flow
-$7.44M
Cap. Flow
% of AUM
-1.31%
Top 10 Holdings %
Top 10 Hldgs %
8.56%
Holding
680
New
121
Increased
206
Reduced
110
Closed
119
Top Buys
| 1 |
Edwards Lifesciences
EW
|
$2.03M |
| 2 |
Caesars Entertainment
CZR
|
$2.01M |
| 3 |
Regions Financial
RF
|
$2.01M |
| 4 |
Global Payments
GPN
|
$1.97M |
| 5 |
EPAM Systems
EPAM
|
$1.96M |
Top Sells
| 1 |
Diamondback Energy
FANG
|
$3.46M |
| 2 |
KeyCorp
KEY
|
$2.81M |
| 3 |
Truist Financial
TFC
|
$2.6M |
| 4 |
Travelers Companies
TRV
|
$2.57M |
| 5 |
MSCI
MSCI
|
$2.1M |
Sector Composition
| 1 | Financials | 19.54% |
| 2 | Technology | 15.83% |
| 3 | Healthcare | 14.42% |
| 4 | Industrials | 12.62% |
| 5 | Energy | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Shattuck Labs
STTK
$47M
| $147K | 0.03% |
50,002
+3,075
| +7% | +$9.04K |
|
527
Alector
ALEC
$238M
| $147K | 0.03% |
23,691
+1,013
| +4% | +$6.27K |
|
528
Cartesian Therapeutics
RNAC
$261M
| $140K | 0.02% |
100,854
| – | – |
|
529
Nkarta
NKTX
$151M
| $139K | 0.02% |
39,196
+17,211
| +78% | +$61.1K |
|
|
IMA
530
ImageneBio, Inc. Common Stock
IMA
$150M
| $136K | 0.02% |
39,461
+9,996
| +34% | +$34.5K |
|
|
PSTX
531
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $126K | 0.02% |
41,008
-25,108
| -38% | -$77.3K |
|
532
Fulcrum Therapeutics
FULC
$351M
| $126K | 0.02% |
44,078
+9,192
| +26% | +$26.2K |
|
533
CytomX Therapeutics
CTMX
$336M
| $124K | 0.02% |
82,415
-65,939
| -44% | -$99.6K |
|
534
Generation Bio
GBIO
$40.4M
| $123K | 0.02% |
28,672
+153
| +0.5% | +$658 |
|
|
TCRR
535
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $107K | 0.02% |
71,046
+3,011
| +4% | +$4.52K |
|
536
Precision BioSciences
DTIL
$57.8M
| $101K | 0.02% |
134,273
| – | – |
|
537
Passage Bio
PASG
$22.7M
| $97.2K | 0.02% |
101,488
+1,236
| +1% | +$1.18K |
|
538
Editas Medicine
EDIT
$231M
| $84.6K | 0.01% |
11,665
| – | – |
|
539
Q32 Bio
QTTB
$20.9M
| $83.6K | 0.01% |
81,119
| – | – |
|
|
SURF
540
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $79.1K | 0.01% |
113,219
+4,795
| +4% | +$3.35K |
|
541
Praxis Precision Medicines
PRAX
$958M
| $59.2K | 0.01% |
73,127
+152
| +0.2% | +$123 |
|
|
KRON
542
DELISTED
Kronos Bio
KRON
| $50.1K | 0.01% |
34,307
+5,030
| +17% | +$7.34K |
|
543
Nektar Therapeutics
NKTR
$568M
| $46.8K | 0.01% |
66,627
+2,226
| +3% | +$1.57K |
|
544
Taysha Gene Therapies
TSHA
$797M
| $44.2K | 0.01% |
55,359
| – | – |
|
545
Cooper Companies
COO
$13.4B
| – | – |
-672
| Closed | -$222K |
|
546
Waste Management
WM
$91.2B
| – | – |
-11,624
| Closed | -$1.82M |
|
547
Western New England Bancorp
WNEB
$257M
| – | – |
-58,027
| Closed | -$549K |
|
548
Amalgamated Financial
AMAL
$870M
| – | – |
-20,548
| Closed | -$473K |
|
549
A-Mark Precious Metals
AMRK
$576M
| – | – |
-16,180
| Closed | -$562K |
|
550
Broadcom
AVGO
$1.4T
| – | – |
-3,364
| Closed | -$1.88M |
|